EX-99.1 2 ss5517697_ex9901.htm JOINT FILING AGREEMENT

 

Exhibit 1

JOINT FILING AGREEMENT

                 

The undersigned hereby agree that Amendment No. 3 to Schedule 13D, dated October 23, 2025, with respect to the common stock of PMV Pharmaceuticals, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Amendment No. 3, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

    

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 27th day of October 2025.

 

  ORBIMED ADVISORS LLC  
       
  By: /s/ Carl L. Gordon              
    Name: Carl L. Gordon  
    Title: Member  
       
  ORBIMED CAPITAL GP V LLC  
       
  By: ORBIMED ADVISORS LLC, its managing member
       
  By: /s/ Carl L. Gordon              
    Name: Carl L. Gordon  
    Title: Member of OrbiMed Advisors LLC